Sol-Gel Technologies Ltd.
IPOHarnessing Dermatological Innovation
Public · Ness Ziona
- Headquarters
- Ness Ziona
- Business Model
- B2B
- Website
- sol-gel.com
- Last Round
- Venture Round
- Rounds
- 2
- Type
- Public
About
Sol-Gel Technologies is a NASDAQ-listed (SLGL) dermatology company leveraging proprietary microencapsulation and formulation technology to develop and commercialize advanced treatments for patients with severe and rare skin conditions, including two FDA-approved products, TWYNEO and EPSOLAY. The company's pipeline extends into additional indications such as Gorlin Syndrome and high-frequency basal cell carcinoma, and it partners with established commercial leaders to accelerate global product rollout.
Summary
Sol-Gel Technologies Ltd. is a Biotech company based in Ness Ziona. Investors include Squadron Capital, Great Point Partners and Affinity Asset Advisors.
Funding History
Sign up to view the funding chart
Create a free account with 25 free credits every month, no card needed, to unlock funding history, valuations, and tech stacks.
May 2026
Sign up to see all 6 rounds
Venture Round through Secondary Market — per-round amounts, valuations, and who invested in each round.
Investors
Similar Companies
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Biopharmaceutical services company
Specialty pharmaceutical company
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/sol-gel-technologies-ltd"><img src="https://indexed.vc/api/badge/company/sol-gel-technologies-ltd" alt="Sol-Gel Technologies Ltd. on Indexed.vc" width="260" height="76" /></a>